NCT05206942View on ClinicalTrials.gov

Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Solid Tumor
Interventions
DIAGNOSTIC_TEST

Doppler ultrasound

Power Doppler measurements will be made using a portable Siemens S2000 or S3000 ultrasound scanner

DIAGNOSTIC_TEST

Long Ensemble Angular-coherence Doppler [LEAD] ultrasound

Long Ensemble Angular-coherence Doppler measurements will be made using a Verasonics Vantage 256 scanner

DIAGNOSTIC_TEST

Contrast-enhanced ultrasound (CEUS)

Contrast-enhanced ultrasound measurements will be made using Lumason IV contrast injection followed by an injection of normal saline

Trial Locations (1)

94305

RECRUITING

Stanford, Palo Alto

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Stanford University

OTHER